Quantedge Capital Pte LTD Ironwood Pharmaceuticals Inc Transaction History

Quantedge Capital Pte LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$8.79 - $11.51 $1.43 Million - $1.87 Million	-162,500 Reduced 90.33%	17,400 $199,000
Q3 2023 Nov 13, 2023	SELL	$8.25 - $11.35 $2.33 Million - $3.2 Million	-282,000 Reduced 61.05%	179,900 $1.73 Million
Q2 2023 Aug 11, 2023	SELL	$10.1 - $11.6 $800,930 - $919,880	-79,300 Reduced 14.65%	461,900 $4.91 Million
Q1 2023 May 12, 2023	BUY	$10.37 - $12.56 $1.98 Million - $2.39 Million	190,500 Added 54.32%	541,200 $5.69 Million
Q4 2022 Feb 14, 2023	BUY	$9.9 - $12.43 $472,230 - $592,911	47,700 Added 15.74%	350,700 $4.35 Million
Q3 2022 Nov 10, 2022	BUY	$10.14 - $12.38 $1.24 Million - $1.52 Million	122,700 Added 68.05%	303,000 $3.14 Million
Q2 2022 Aug 12, 2022	BUY	$11.05 - $12.72 $1.99 Million - $2.29 Million	180,300 New	180,300 $2.08 Million

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $527M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Quantedge Capital Pte LTD, based on Form 13F filings with the SEC.

Stay updated on Quantedge Capital Pte LTD with notifications on news.